Aim:The aim of this study was to analyze the distribution of human papillomavirus (HPV) genotypes among women with genital warts in the Beijing region of China. Methods: A total of 350 women diagnosed with genital warts between 2014 and 2016 were analyzed by real-time polymerase chain reaction (PCR) to test for high-risk and low-risk HPV subtypes. Results: The results show that 52.6% (184/350) of cases were positive for HPV6+11. The three most common high-risk HPVs detected were HPV52, HPV16 and HPV58, detected in 12.0% (42/350), 10.6% (37/350) and 10.0% (35/350) of all cases, respectively. Conclusion: These results indicate that vaccines targeting HPV subtypes 6, 11, 16, 52 and 58 would have the greatest impact among sexually active women living in Beijing. Human papillomaviruses (HPVs) are small double-stranded DNA viruses that belong to the family of papillomavirus [1]. There are as many as 170 HPV genotypes have been identified [2], and approximately 40 kinds of these types specially infect the anogenital tract [3]. Genital warts are evident skin or mucosal growths in the anogenital area display as flat, papular or pedunculated growths on the genital mucosa [4]. Genital warts are one of the most common sexually transmitted diseases with a high prevalence (0.5%) in Asia [5,6]. The disease results from infection with 'low-risk' HPV subtypes [7]. Infection with 'high-risk' HPV is associated with the development of precancerous lesions [8]. Treatments on genital warts are mainly divided into medications and surgery, medications include imiquimod, podophyllin, podofilox and trichloroacetic acid, surgery include freezing with liquid nitrogen, electrocautery, surgical excision and laser treatments [9,10]. Although the short-time effect of above treatment is good, the transmission rate of the related HPV infection is as high as 65%, with a high risk of recurrence [7]. Thus, effective prevention against HPV transmission and infection is essential. Accordingly, many countries have implemented HPV vaccination programs.A recent study by Chang et al. [11] indicates that the distribution of HPV subtypes differs among various regions throughout China. Comparison of other studies reporting on HPV prevalence in China indicates wide geographic variability in subtype distribution [12], thus undermining the selection of the most effective vaccine. Up to date, several vaccines have been developed to prevent HPV infection. Gardisil is a quadrivalent vaccine containing four genotypes, namely 16, 18, 6 and 11; and Cervarix (GSK) is a bivalent vaccine containing 16 and 18. In addition to providing excellent protection against the HPV types contained in the vaccine, Gardisil has also demonstrated significant cross-protection to other oncogenic types in both naive and previously infected women [13].In order to identify the distribution of HPV subtypes in the Beijing area, samples collected from women with genital warts treated at a sexually transmitted disease clinic were examined. The results will contribute to the data